机译:可溶性血浆HLA肽组可能成为癌症生物标志物的潜在来源
Department of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel;
rnDepartment of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel;
rnIBM Haifa Research Laboratory, Haifa 31905, Israel;
Bruce Rappaport Faculty of Medicine, Technion-lsrael Institute of Technology, Department of Hematology and Bone Marrow Transplantation,Rambam Health Care Campus, Haifa 31096, Israel;
rnBruce Rappaport Faculty of Medicine, Technion-lsrael Institute of Technology, Department of Hematology and Bone Marrow Transplantation,Rambam Health Care Campus, Haifa 31096, Israel;
rnDepartment of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel;
机译:来自人血清或血浆的可溶性HLA级联I复合物的纯化为生物标志物发现所需的高质量免疫肽
机译:血浆可溶性HLA-G是诊断大肠癌,胃癌,食道癌和肺癌的潜在生物标志物。
机译:精子等离子体中可溶性TCR和HLA的检测:精子质量评价的潜在生物标志物
机译:人类胰腺组织和血浆肽的分析显示出胰腺癌的潜在生物标志物
机译:表演沉默的I型人白细胞抗原(HLA-1):一种新的生物标志物和前列腺癌治疗靶标
机译:专题文章从封面开始:可溶性血浆HLA肽组是癌症生物标志物的潜在来源
机译:可溶性血浆HLA肽组可能成为癌症生物标志物的潜在来源
机译:鉴定乳腺癌血清生物标志物:一种新的逆转录病毒库筛选,以确定乳腺癌可溶性胞外域蛋白质组